Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1263 results for "sun pharma"

Sun Pharma Advanced Research Q1 net loss narrows

SPARC receives positive response from USFDA for eye treatment ...

New Delhi, Aug 1 (UNI) Sun Pharma Advanced Research Company Ltd. (SPARC) today said it has received a complete response letter (CRL) from USFDA for Latanoprost, its New Drug Application (NDA) for United News of India, 19 hours ago
SPARC reports net loss of Rs 1.65 cr in Q1 Hindu Business Line, 21 hours ago
New Indian Express

Pharma Upgradation the Way Out

Rs 10 and 3 minutes is all drug testing companies need to take an ECG or an electro cardiogram that assesses heart functionality. Clearly, it's a simple, cost-effective procedure. But the Indian Contract Research Organisations (CROs), are allegedly ...
 New Indian Express4 hours ago
Money Today

Sun Pharma Adv. Res reports Profit after tax of Rs -16.50 Mln, in the June 2015 quarter

SENSEX 28114.56 409.21 1.48% NIFTY 8532.85 111.05
 Finalaya.com19 hours ago Sun Pharma Q4 profit falls to Rs 888 cr; Ranbaxy merger hurts  Money Today2 months ago Sun Pharma reports Q4 net profit at Rs 888 crore  Business Standard2 months ago Sun Pharma Q4 profit at Rs 888 crore; Ranbaxy merger hurts  Jagran Post2 months ago
Financial Express

BSE Sensex surges 409 points led by banking, pharma stocks; NSE Nifty above 8,500

The benchmark BSE Sensex , NSE Nifty opened in green on Friday, thereby continuing Thursday's winning streak despite mixed global trends today. (Express Photo) The benchmark BSE Sensex rocketed 409 points at 28,114.56 on Friday on continued ...
 Financial Express1 day ago Sensex ends up 142pts, Nifty below 8450; Dr Reddy's up 5%  Money Control2 days ago Nifty hovers around 8450, Sensex strong; ITC gains 2%  Money Control2 days ago Sensex zooms over 200 pts; HUL HDFC up, IT stocks fall  Money Control2 days ago

Be stock-specific; prefer Dr Reddy's, Lupin among pharma names: Pankaj Pandey

In a chat with ET Now, Pankaj Pandey, Head of Research,, shares his view on pharma stocks. ET Now: I do not know how closely you look at Glenmark, but the trend that we have seen in pharma, is that bad numbers from Lupin, Sun Pharma ...
 Economic Times1 day ago FY16 not a good year for large drug makers; prefer midcap pharma stocks: Hemindra Hazari  Economic Times5 days ago

Transport Corp, SPARC numbers on weekend

This weekend will see a host of companies declaring their financial performance for the April-June quarter. While Sun Pharma Advanced Research Co (SPARC), Fiem Industries, KS Oils, SREI Infra Finance, Seshasayee Paper, Transport Corporation of ...
 Hindu Business Line1 day ago

Sensex hits 28,000 mark; rate-sensitive shares rise

Markets have extended gains and are trading near day's high led by strong buying among pharma, auto and financial shares. By 11:10, the Sensex was higher by 295 points at 28,001 and the Nifty gained 76 points at 8,498 levels. Sensex and Nifty have ...
 Smart Investor1 day ago
India Infoline

Sun Pharma May File New Drug Application with USFDA: Shanghvi

HYDERABAD: India's largest drugmaker Sun Pharma may file application for a new drug with the US Food and Drug Administration in next two to three years, the company's Managing Director Dilip Shanghvi said today. The firm's research arm SPARC (Sun ...
 New Indian Express2 days ago Top Pharma news of the day  India Infoline2 days ago After acquiring Ranbaxy for $3.2 bn, Sun Pharma cuts staff in R&D division  Economic Times2 days ago Sun Pharma cuts staff in R&D division  Economic Times2 days ago

No sunshine for Sun Pharma in FY16

Brokerages have cut the company's FY16 earnings estimates between 16% and 29% with target prices too coming down to the Rs 700-800 band Steep downward revisions in earnings by brokerages following the profit warning for FY16 by the Sun Pharma management saw the stock lose over 14 per cent in trade on Tuesday to Rs 815 levels. Brokerages have cut the company's FY16 earnings estimates between 16 per cent and 29 per cent with target prices too coming down to the Rs 700-800 band. The company had ...
 Rediff.com1 week ago Sun Pharma’s muted guidance for FY16 triggers stock carnage  The Financial Chronicle1 week ago Sun Pharma shares fall 16% as company expects a hit on profit  Financial Express1 week ago Sun Pharma shares fall record 15% on profit warning  Livemint.com1 week ago

Israel-Based Company Purchases Allergan's Generics Business for (Dollar) 40 Billion

Teva Pharmaceutical Industries purchases Allergan's generics business for $40.5-billion. This may help generic-drug makers to acquire products that may be divested s part of the antitrust procedures in the US and fill their portfolio gaps. Teva ...
 MedIndia3 days ago Teva-Allergan deal signals both opportunities, threats for Indian pharma  Business Today India4 days ago Teva-Allergan deal a booster for Indian companies  Economic Times5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
Get updated on latest news & your favorite topics right in your inbox!
More     Less